These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36434677)

  • 21. Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies.
    Schweitzer N; Vogel A
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):345-53. PubMed ID: 25966433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrahepatic Cholangiocarcinoma with High Microsatellite Instability and Tumor Mutation Burden That Responded Significantly to Pembrolizumab but Perforated within a Short Period.
    Yamazaki S; Kubota K; Shimizu A; Notake T; Umemura K; Kamachi A; Goto T; Tomida H; Yamashita N; Sato M; Kanno H; Soejima Y
    Intern Med; 2024 Apr; 63(8):1105-1112. PubMed ID: 37779076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFIRI for Advanced Intrahepatic Cholangiocarcinoma as Second-Line and Successive Treatment: A Real-World Study.
    Huang P; Huang X; Zhou Y; Yang G; Sun Q; Shi G; Chen Y
    Can J Gastroenterol Hepatol; 2022; 2022():9680933. PubMed ID: 36199981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report.
    Toshida K; Itoh S; Yoshizumi T; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oki E; Nakamura Y; Yoshino T; Mori M
    Clin J Gastroenterol; 2021 Oct; 14(5):1459-1463. PubMed ID: 34085164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infigratinib in patients with advanced cholangiocarcinoma with
    Makawita S; K Abou-Alfa G; Roychowdhury S; Sadeghi S; Borbath I; Goyal L; Cohn A; Lamarca A; Oh DY; Macarulla T; T Shroff R; Howland M; Li A; Cho T; Pande A; Javle M
    Future Oncol; 2020 Oct; 16(30):2375-2384. PubMed ID: 32580579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
    Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma.
    Lee GW; Kang JH; Kim HG; Lee JS; Lee JS; Jang JS
    Am J Clin Oncol; 2006 Apr; 29(2):127-31. PubMed ID: 16601429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precision approaches for cholangiocarcinoma: progress in clinical trials and beyond.
    Uson Junior PLS; Borad MJ
    Expert Opin Investig Drugs; 2022 Jan; 31(1):125-131. PubMed ID: 34904492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series.
    Abdelrahim M; Al-Rawi H; Esmail A; Xu J; Umoru G; Ibnshamsah F; Abudayyeh A; Victor D; Saharia A; McMillan R; Al Najjar E; Bugazia D; Al-Rawi M; Ghobrial RM
    Curr Oncol; 2022 May; 29(5):3585-3594. PubMed ID: 35621680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.
    Sia D; Tovar V; Moeini A; Llovet JM
    Oncogene; 2013 Oct; 32(41):4861-70. PubMed ID: 23318457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of hepatobiliary carcinogenesis.
    Nault JC; Zucman-Rossi J
    Semin Liver Dis; 2011 May; 31(2):173-87. PubMed ID: 21538283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robust Response to Futibatinib in a Patient With Metastatic FGFR-Addicted Cholangiocarcinoma Previously Treated Using Pemigatinib.
    Rengan AK; Denlinger CS
    J Natl Compr Canc Netw; 2022 Apr; 20(5):430-435. PubMed ID: 35378504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
    Andersen JB; Spee B; Blechacz BR; Avital I; Komuta M; Barbour A; Conner EA; Gillen MC; Roskams T; Roberts LR; Factor VM; Thorgeirsson SS
    Gastroenterology; 2012 Apr; 142(4):1021-1031.e15. PubMed ID: 22178589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of systemic chemotherapy of GEM+CBDCA+5-FU/LV and hepatic arterial infusion of CDDP in a case of advanced, combined hepatocellular-cholangiocarcinoma with multiple lung metastases].
    Tani S; Murata S; Tamura M; Fukunaga K; Morita M; Hirata Y; Iida H; Kakuno A; Nishigami T; Yamanaka N
    Nihon Shokakibyo Gakkai Zasshi; 2011 Nov; 108(11):1892-901. PubMed ID: 22056711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic therapy for hepatocellular carcinoma and cholangiocarcinoma.
    Chung V
    Surg Oncol Clin N Am; 2015 Jan; 24(1):187-98. PubMed ID: 25444475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine and cisplatin combination chemotherapy in intrahepatic cholangiocarcinoma as second-line treatment: report of four cases.
    Lee MA; Woo IS; Kang JH; Hong YS; Lee KS
    Jpn J Clin Oncol; 2004 Sep; 34(9):547-50. PubMed ID: 15466829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years.
    Pracht M; Le Roux G; Sulpice L; Mesbah H; Manfredi S; Audrain O; Boudjema K; Raoul JL; Boucher E
    Chemotherapy; 2012; 58(2):134-41. PubMed ID: 22572213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma.
    Charoentum C; Thongprasert S; Chewaskulyong B; Munprakan S
    World J Gastroenterol; 2007 May; 13(20):2852-4. PubMed ID: 17569122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress.
    Gadaleta-Caldarola G; Rizzo A; Dadduzio V; Lombardi L; Gadaleta-Caldarola A; Infusino S; Cusmai A; Citrigno C; Palmiotti G
    Curr Oncol; 2022 Oct; 29(10):7925-7931. PubMed ID: 36290903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gefitinib and gemcitabine coordinately inhibited the proliferation of cholangiocarcinoma cells.
    Nakajima Y; Takagi H; Kakizaki S; Horiguchi N; Sato K; Sunaga N; Mori M
    Anticancer Res; 2012 Dec; 32(12):5251-62. PubMed ID: 23225424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.